Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)
Article in Clinical Cancer Research (July 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (July 2024)
Article in Vaccines (July 2024)
Article in Journal of Peptide Science (April 2024)